-
Since then, the vast majority of more than 44, 000 people who were homeless have achieved self-sufficiency through the A Safe Haven holistic model.
WHITEHOUSE: A Safe Haven
-
With this worldview, no company or business model is safe from government regulation.
FORBES: Big Broadband's Secret Plan to Deliver Wildly Popular Content and Apps to Happy Consumers
-
The gravity-based system responded as it was designed to, circulating water and steam in a continuous loop to keep the scale-model reactor at a safe temperature automatically.
CNN: Today/Tomorrow - Helping nuclear plants keep their cool
-
With that in mind, the Environmental Defense Fund, Southwestern Energy and other progressive gas producers and environmental groups are working to develop a model regulatory framework for safe drilling that can serve as the foundation for better operations.
WSJ: Is Natural Gas the Road to a Clean Energy Future?
-
That is a lot better than nothing, at least for nuclear fallout (for which the model was first developed): there the case for being safe not sorry is overwhelming, and once the fallout has fallen, a Geiger counter will tell you whether the model's forecasts of which places would be affected have turned out to be right.
ECONOMIST: Volcanoes and air travel: Small eruption in Iceland | The
-
The magnetic strength of the headphones varies by brand and model, but the study found that 3 centimeters was a safe distance for all.
CNN: Study: Headphones could interfere with pacemakers
-
The companies said the collaboration reflects the shared belief that the development and commercialization of biosimilar products will not follow a pure brand or generic model and will require significant expertise, infrastructure and investment to ensure safe, reliably supplied therapies.
FORBES: Cancer Drug Partnerships: Immunogen to Collaborate with Lilly, Amgen Partners with Watson
-
The typical clinical trial model may not be best suited for generating evidence that a drug is safe and effective against diseases where patient enrollment can be difficult and diseases progress slowly and unevenly over a long period of time, according to Steven Grossman, who worked on the original Orphan Drug Act in 1983 and is now a policy and regulatory consultant.
FORBES: Orphan Drugs: 'Rare' Opportunities To Make Money